Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dean J. Naisbitt, PhDa, John Farrell, BSca, Gavin Wong, MBChBb, Jan p

Published byMarkku Sariola Modified over 5 years ago

Similar presentations

Presentation on theme: "Dean J. Naisbitt, PhDa, John Farrell, BSca, Gavin Wong, MBChBb, Jan p"— Presentation transcript:

1 Characterization of drug-specific T cells in lamotrigine hypersensitivity 
Dean J. Naisbitt, PhDa, John Farrell, BSca, Gavin Wong, MBChBb, Jan p.H. Depta, BScc, Charlotte C. Dodd, PhDa, Josephine E. Hopkins, BSca, Claire A. Gibney, BSca, David W. Chadwick, FRCPd, Werner J. Pichler, MDc, Munir Pirmohamed, FRCPa, B.Kevin Park, PhDa  Journal of Allergy and Clinical Immunology  Volume 111, Issue 6, Pages (June 2003) DOI: /mai Copyright © 2003 Mosby, Inc. Terms and Conditions

2 Fig. 1 a and b , Proliferation of PBMCs from LTG-hypersensitive patients and controls. c, Proliferation of PBMCs from patient 1 with LTG and related compounds. Statistical analysis compares incubations with and without antigen (*P < .05). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions

3 Fig. 2 Cell surface expression of the skin-homing molecule CLA on LTG- and TT-specific T-cell clones. Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions

4 Fig. 3 a, Phenotype, proliferation, and cytotoxicity of LTG-specific T-cell clones. b, Cytotoxicity was inhibited by concanamycin A, an inhibitor of perforin killing. c, Perforin was secreted by LTG-stimulated T-cell clones. d, No staining was found in incubations without T cells. Statistical analysis compares incubations with and without antigen (*P < .05). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions

5 Fig. 4 a, Proliferation and chemokine secretion (b and c) by LTG-specific T-cell clones. Statistical analysis was performed by comparing proliferation or chemokine release in the presence and absence of antigen (*P < .05). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions

6 Fig. 5 Mechanism of LTG presentation to T-cell clones. a and b, LTG is presented on HLA-DR and HLA-DQ by HLA-matched antigen-presenting cells. c and d, LTG is presented to T cells by B-LCLs in the absence of drug metabolism. e and f, LTG is presented by B-LCLs in the absence of antigen processing. Statistical analysis compares incubations with and without antigen (*P < .05). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions

7 Fig. 6 Proliferation of LTG-specific T-cell clones stimulated with LTG and related compounds. Colors refer to individual clones. Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions

8 Fig. 7 Scheme depicting the chemical, cellular, and molecular pathophysiology of LTG hypersensitivity. Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions

Download ppt "Dean J. Naisbitt, PhDa, John Farrell, BSca, Gavin Wong, MBChBb, Jan p"

Similar presentations

Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia.

Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia.
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Daniela P. Metz, PhDa, Annette S

Daniela P. Metz, PhDa, Annette S
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells  Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.

Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells  Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.
Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison.

Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison.
The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics  Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,

The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics  Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,
The environmental pollutant pyrene induces the production of IL-4

The environmental pollutant pyrene induces the production of IL-4
Christine M. Braun, BA, Shau-Ku Huang, PhD, Gregory G

Christine M. Braun, BA, Shau-Ku Huang, PhD, Gregory G
Predominance of type 2 cytokine–producing CD4+ and CD8+ cells in patients with atopic dermatitis  Masatoshi Nakazawa, DVMa, Nakako Sugi, MDb, Hiroshi.

Predominance of type 2 cytokine–producing CD4+ and CD8+ cells in patients with atopic dermatitis  Masatoshi Nakazawa, DVMa, Nakako Sugi, MDb, Hiroshi.
Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug- induced cutaneous eruptions  Nikhil Yawalkar, MD, Maithili Shrikhande,

Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug- induced cutaneous eruptions  Nikhil Yawalkar, MD, Maithili Shrikhande,
Mast cell–T cell interactions

Mast cell–T cell interactions
Youngil I. Koh, MD a, Inseon S

Youngil I. Koh, MD a, Inseon S
Practice Notes from the AAAI

Practice Notes from the AAAI
Rosaura Casas, MSc, Malin F

Rosaura Casas, MSc, Malin F
Product characteristics and pharmacokinetics of intranasal ipratropium bromide  Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.

Product characteristics and pharmacokinetics of intranasal ipratropium bromide  Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.
T-cell involvement in delayed-type hypersensitivity reactions to infliximab  Maria Jose Torres, MD, PhD, Patrícia Chaves, PhD, Inmaculada Doña, MD, Natalia.

T-cell involvement in delayed-type hypersensitivity reactions to infliximab  Maria Jose Torres, MD, PhD, Patrícia Chaves, PhD, Inmaculada Doña, MD, Natalia.
Erythema multiforme to phenobarbital: Involvement of eosinophils and T cells expressing the skin homing receptor  F.Jesus Gonzalez, PhDa, Maria J. Carvajal,

Erythema multiforme to phenobarbital: Involvement of eosinophils and T cells expressing the skin homing receptor  F.Jesus Gonzalez, PhDa, Maria J. Carvajal,
Donor-specific cellular immune response against human cardiac valve allografts  Franciska Hoekstra, MDa, Christiaan Knoop, BSca, Len Vaessen, BSca, Claas.

Donor-specific cellular immune response against human cardiac valve allografts  Franciska Hoekstra, MDa, Christiaan Knoop, BSca, Len Vaessen, BSca, Claas.

Similar presentations

Ads by Google